CellCept (mycophenolate mofetil)
Phase 1Completed 1 views this week 0 watching💤 Quiet
Interest: 29/100
29
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
MPO-ANCA Vasculitis
Conditions
MPO-ANCA Vasculitis, Microscopic Polyangiitis
Trial Timeline
Dec 1, 2002 → Jul 1, 2008
NCT ID
NCT00405860About CellCept (mycophenolate mofetil)
CellCept (mycophenolate mofetil) is a phase 1 stage product being developed by Roche for MPO-ANCA Vasculitis. The current trial status is completed. This product is registered under clinical trial identifier NCT00405860. Target conditions include MPO-ANCA Vasculitis, Microscopic Polyangiitis.
Hype Score Breakdown
Clinical
6
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (2)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00281619 | Pre-clinical | Completed |
| NCT00405860 | Phase 1 | Completed |